Talk:Pegfilgrastim

Cost of Neulasta
Cancer patients (and their insurance) pays an average of $3,000+ per shot, where one shot is administered for each chemo treatment. It would be nice to add a section in this article explaining why the cost is so high (without being political). When was the drug patented and when will the patent expire? Is it expensive to manufacture? — Preceding unsigned comment added by Ttwiv (talk • contribs) 00:30, 28 May 2011 (UTC)


 * I am a cancer patient who will be given this med soon. IMO, there is no way to explain the high price without getting political. As a proud part of U.S. capitalism, pharmaceutical companies charge what the market will bear. Developing a new med that ~80% of cancer chemotherapy patients absolutely require to meet their chemotherapy timetable doesn't happen often, so they squeeze whatever they can get. Whether this is ethical and fair, and balanced against their general development and other overhead costs is an open question, since there is no transparency and little regulation, and they lobby to keep it that way. David Spector (talk) 00:26, 16 November 2016 (UTC)

India trade names
can you add India trade names. 65.175.243.206 (talk) 21:46, 13 September 2015 (UTC)

Biosimilars
The section does not seem to be of any use. There is no value in specifying when all of the various biosimilar forms were approved by various agencies. Barring any dissent I am going to remove this whole section. Kimen8 (talk) 23:14, 29 January 2024 (UTC)


 * It's been some time and WP:SILENCE is consensus. I'm removing this section. Kimen8 (talk) 17:50, 21 March 2024 (UTC)


 * The contents have been put here in in case someone wishes to restore at some point in the future without digging through the history:

Kimen8 (talk) 17:59, 21 March 2024 (UTC)